Tomer Cooks

Medicine & Life Sciences

1. Alpha Particles 100%
2. Neoplasms 92%
3. Extracellular Vesicles 73%
4. Tumor Microenvironment 56%
5. Microbiota 41%
6. thorium X 36%
7. Lung Neoplasms 32%
8. Inflammation 32%
9. Macrophages 32%
10. Comamonadaceae 31%
11. Squamous Cell Carcinoma 30%
12. Colorectal Neoplasms 30%
13. Exosomes 29%
14. p53 Genes 27%
15. Radiotherapy 25%
16. Head and Neck Neoplasms 20%
17. Immunotherapy 19%
18. Mutation 18%
19. Drug Therapy 18%
20. Lung 17%
21. Brachytherapy 16%
22. Bifidobacterium longum 15%
23. Therapeutics 15%
24. Colonic Neoplasms 15%
25. Growth 15%
26. NF-kappa B 13%
27. Galectin 3 13%
28. Mutant Proteins 13%
29. Temozolomide 12%
30. Heterografts 12%
31. Nude Mice 12%
32. Glioblastoma 11%
33. Combination Drug Therapy 11%
34. Seeds 11%
35. Bevacizumab 11%
36. Colon 11%
37. Ubiquitination 11%
38. Neoplastic Stem Cells 11%
39. Proteins 10%
40. Anti-Inflammatory Agents 10%
41. Histones 9%
42. Genome 9%
43. Proteomics 9%
44. Breast Neoplasms 9%
45. Publications 8%
46. Cytoplasm 8%
47. Carcinogenesis 8%
48. trametinib 8%
49. In Vitro Techniques 7%
50. Software 7%